Company / Depreciation & Amortization
Fortress Biotech, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.0M
FY2025
5-year range
$1.0M / $3.1M
FY2021-FY2025
Trend
-53.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -11.6%.
Improved from $3M to $1M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -26.6%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -11.6%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 53.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2023.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0M | -53.4% |
| FY2024 | $2.2M | -28.3% |
| FY2023 | $3.1M | +18.3% |
| FY2022 | $2.6M | +15.3% |
| FY2021 | $2.3M | +18.6% |
| FY2020 | $1.9M | +38.0% |
| FY2019 | $1.4M | +91.9% |
| FY2018 | $726.0K | +2692.3% |
| FY2017 | $26.0K | +13.0% |
| FY2016 | $23.0K | +35.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026